Stock Events

Stock Events

Halozyme Therapeutics (HALO) Q1 2017 Earnings

28FebConfirmed

Q2 2016

Q3 2016

Q4 2016

Q1 2017

-0.28

-0.24

-0.2

-0.16

Details

Expected EPS

-0.27

Actual EPS

-0.21

Surprise EPS

0.06

Surprise Percent

+22.22%

Description

Halozyme Therapeutics (HALO) has reported earnings of -0.21 per share for Q1 2017.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.